Soluble signalling factors derived from differentiated cartilage tissue affect chondrogenic differentiation of rat adult marrow stromal cells

Cellular Physiology and Biochemistry

Volumn 20, Issue 5, 2007, Pages 665-678

  Ahmed, Nazish ^a,b   Dreier, Rita ^c   Göpferich, Achim ^d   Grifka, Joachim ^a   Grässel, Susanne ^a,b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b Centre for Medical Biotechnology   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cartilage; Chondrogenic differentiation; Coculture; Collagen X; MMP 13; Rat mesenchymal stem cells; Signalling factors; Sox9

Indexed keywords

COLLAGEN TYPE 10; COLLAGENASE 3; GROWTH FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSCRIPTION FACTOR SOX9; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; ARTICULAR CARTILAGE; BONE MARROW; CELL CULTURE; CHONDROGENESIS; COCULTURE; EXPLANT; IN VITRO STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SUPERNATANT;

RATTUS;

EID: 34548370677     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107728     Document Type: Article

References (50)

1. Magne D, Vinatier C, Julien M, Weiss P, Guicheux J: Mesenchymal stem cell therapy to rebuild cartilage. Trends Mol Med 2005;11(11):519-526.
2. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L: Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994;331(14):889-895.
3. Cancedda R, Dozin B, Giannoni P, Quarto R: Tissue engineering and cell therapy of cartilage and bone. Matrix Biol 2003;22(1):81-91.
4. Lefebvre V, Smits P: Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 2005;75(3):200-212.
5. Barry F, Boynton RE, Liu B, Murphy JM: Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res 2001;268(2):189-200.
6. Mendler M, Eich-Bender SG, Vaughan L, Winterhalter KH, Bruckner P: Cartilage contains mixed fibrils of collagen types II, IX, and XI. J Cell Biol 1989;108(1):191-197.
7. Reddi AH: Bone and cartilage differentiation. Curr Opin Genet Dev 1994;4(5):737-744.
8. Wu CW, Tchetina EV, Mwale F, Hasty K, Pidoux I, Reiner A, Chen J, Van Wart HE, Poole AR: Proteolysis involving matrix metalloproteinase 13 (collagenase-3) is required for chondrocyte differentiation that is associated with matrix mineralization. J Bone Miner Res 2002;17(4):639-651.
9. Johansson N, Saarialho-Kere U, Airola K, Herva R, Nissinen L, Westermarck J, Vuorio E, Heino J, Kahari VM: Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn 1997;208(3):387-397.
10. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G: Biochemical characterization of human collagenase-3. J Biol Chem 1996;271(3):1544-1550.
11. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF, Hambor JE: Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996;97(3):761-768.
12. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N: VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999;5(6):623-628.
13. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B: Sox9 is required for cartilage formation. Nat Genet 1999;22(1):85-89.
14. de Crombrugghe B, Lefebvre V, Behringer RR, Bi W, Murakami S, Huang W: Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol 2000;19(5):389-394.
15. Mundlos S, Olsen BR: Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development-transcription factors and signaling pathways. FASEB J 1997;11(2):125-132.
16. Lefebvre V, Behringer RR, de Crombrugghe B: L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage 2001;9 Suppl A:S69-S75.
17. Inada M, Yasui T, Nomura S, Miyake S, Deguchi K, Himeno M, Sato M, Yamagiwa H, Kimura T, Yasui N, Ochi T, Endo N, Kitamura Y, Kishimoto T, Komori T: Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 1999;214(4):279-290.
18. Goldring MB, Tsuchimochi K, Ijiri K: The control of chondrogenesis. J Cell Biochem 2006;97(1):33-44.
19. Porte D, Tuckermann J, Becker M, Baumann B, Teurich S, Higgins T, Owen MJ, Schorpp-Kistner M, Angel P: Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone. Oncogene 1999;18(3):667-678.
20. Ahmed N, Vogel B, Rohde E, Strunk D, Grifka J, Schulz MB, Grassel S: CD45-positive cells of haematopoietic origin enhance chondrogenic marker gene expression in rat marrow stromal cells. Int J Mol Med 2006;18(2):233-240.
21. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU: In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998;238(1):265-272.
22. Mok SS, Masuda K, Hauselmann HJ, Aydelotte MB, Thonar EJ: Aggrecan synthesized by mature bovine chondrocytes suspended in alginate. Identification of two distinct metabolic matrix pools. J Biol Chem 1994;269(52):33021-33027.
23. Bruckner P, Horler I, Mendler M, Houze Y, Winterhalter KH, Eich-Bender SG, Spycher MA: Induction and prevention of chondrocyte hypertrophy in culture. J Cell Biol 1989;109(5):2537-2545.
24. Grassel S, Timpl R, Tan EM, Chu ML: Biosynthesis and processing of type XVI collagen in human fibroblasts and smooth muscle cells. Eur J Biochem 1996;242(3):576-584.
25. Bohme K, Winterhalter KH, Bruckner P: Terminal differentiation of chondrocytes in culture is a spontaneous process and is arrested by transforming growth factor-beta 2 and basic fibroblast growth factor in synergy. Exp Cell Res 1995;216(1):191-198.
26. Etoh T, Inoue H, Yoshikawa Y, Barnard GF, Kitano S, Mori M: Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness. Gut 2000;47(1):50-56.
27. Majumdar MK, Banks V, Peluso DP, Morris EA: Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J Cell Physiol 2000;185(1):98-106.
28. Caterson EJ, Nesti LJ, Li WJ, Danielson KG, Albert TJ, Vaccaro AR, Tuan RS: Three-dimensional cartilage formation by bone marrow-derived cells seeded in polylactide/alginate amalgam. J Biomed Mater Res 2001;57(3):394-403.
29. Furumatsu T, Tsuda M, Taniguchi N, Tajima Y, Asahara H: Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J Biol Chem 2005;280(9):8343-8350.
30. Yin M, Pacifici M: Vascular regression is required for mesenchymal condensation and chondrogenesis in the developing limb. Dev Dyn 2001;222(3):522-533.
31. Bosnakovski D, Mizuno M, Kim G, Takagi S, Okumura M, Fujinaga T: Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol Bioeng 2006;93(6):1152-1163.
32. von der MK, Kirsch T, Nerlich A, Kuss A, Weseloh G, Gluckert K, Stoss H: Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum 1992;35(7):806-811.
33. Jikko A, Kato Y, Hiranuma H, Fuchihata H: Inhibition of chondrocyte terminal differentiation and matrix calcification by soluble factors released by articular chondrocytes. Calcif Tissue Int 1999;65(4):276-279.
34. Babarina AV, Mollers U, Bittner K, Vischer P, Bruckner P: Role of the subchondral vascular system in endochondral ossification: endothelial cell-derived proteinases derepress late cartilage differentiation in vitro. Matrix Biol 2001;20(3):205-213.
35. Bittner K, Vischer P, Bartholmes P, Bruckner P: Role of the subchondral vascular system in endochondral ossification: endothelial cells specifically derepress late differentiation in resting chondrocytes in vitro. Exp Cell Res 1998;238(2):491-497.
36. Bohme K, Winterhalter KH, Bruckner P: Terminal differentiation of chondrocytes in culture is a spontaneous process and is arrested by transforming growth factor-beta 2 and basic fibroblast growth factor in synergy. Exp Cell Res 1995;216(1):191-198.
37. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G: The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 1996;271(29):17119-17123.
38. Knauper V, Cowell S, Smith B, Lopez-Otin C, O'Shea M, Morris H, Zardi L, Murphy G: The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997;272(12):7608-7616.
39. Cowell S, Knauper V, Stewart ML, d'Ortho MP, Stanton H, Hembry RM, Lopez-Otin C, Reynolds JJ, Murphy G: Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J 1998;331 ( Pt 2):453-458.
40. Knauper V, Cowell S, Smith B, Lopez-Otin C, O'Shea M, Morris H, Zardi L, Murphy G: The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997;272(12):7608-7616.
41. Inada M, Wang Y, Byrne MH, Rahman MU, Miyaura C, Lopez-Otin C, Krane SM: Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci U S A 2004;101(49):17192-17197.
42. Stickens D, Behonick DJ, Ortega N, Heyer B, Hartenstein B, Yu Y, Fosang AJ, Schorpp-Kistner M, Angel P, Werb Z: Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 2004;131(23):5883-5895.
43. Kim IS, Otto F, Zabel B, Mundlos S: Regulation of chondrocyte differentiation by Cbfa1. Mech Dev 1999;80(2):159-170.
44. Zheng Q, Zhou G, Morello R, Chen Y, Garcia-Rojas X, Lee B: Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J Cell Biol 2003;162(5):833-842.
45. Pufe T, Petersen W, Tillmann B, Mentlein R: The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 2001;44(5):1082-1088.
46. Pfander D, Kortje D, Zimmermann R, Weseloh G, Kirsch T, Gesslein M, Cramer T, Swoboda B: Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann Rheum Dis 2001;60(11):1070-1073.
47. Pufe T, Harde V, Petersen W, Goldring MB, Tillmann B, Mentlein R: Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes. J Pathol 2004;202:367-374.
48. Matsushita K, Motani R, Sakuta T, Yamaguchi N, Koga T, Matsuo K, Nagaoka S, Abeyama K, Maruyama I, Torii M: The role of vascular endothelial growth factor in human dental pulp cells: induction of chemotaxis, proliferation, and differentiation and activation of the AP-1-dependent signaling pathway. J Dent Res 2000;79(8):1596-1603.
49. Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY, Stetler-Stevenson WG: TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 2003;114(2):171-180.
50. Stetler-Stevenson WG, Seo DW: TIMP-2: an endogenous inhibitor of angiogenesis. Trends Mol Med 2005;11(3):97-103.